AWM
EBS icon

AE Wealth Management’s Emergent Biosolutions EBS Stock Holding History

AE Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,831
Closed -$29.9K – 1249
2024
Q1 		$29.9K Sell
11,831
-7,324
-38% -$16.5K ﹤0.01% 1137
2023
Q4 		$34.9K Buy
+19,155
New +$45K ﹤0.01% 1994
2023
Q3 		– Sell
-39,413
Closed -$290K – 1984
2023
Q2 		$290K Sell
39,413
-3,030
-7% -$28.1K ﹤0.01% 1631
2023
Q1 		$440K Buy
+42,443
New +$513K ﹤0.01% 1406

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AE Wealth Management's EBS Position: Q2 2024 in Review

AE Wealth Management sold out of Emergent Biosolutions (EBS) in Q2 2024, closing a stake of 11,831 shares — an estimated $29.9K sold.

AE Wealth Management first reported a position in EBS in Q1 2023 and held it in 4 quarters. The position peaked at $440K in Q1 2023. 141 funds tracked by Wall St. Rank hold EBS as of Q2 2024.

  • AE Wealth Management reported no remaining Emergent Biosolutions position as of Q2 2024 after selling out during the quarter.
  • AE Wealth Management sold 11,831 Emergent Biosolutions shares in Q2 2024, an estimated $29.9K.
  • AE Wealth Management first reported a position in Emergent Biosolutions in Q1 2023 and held it in 4 quarters.
  • AE Wealth Management's Emergent Biosolutions position peaked at $440K in Q1 2023.
  • 141 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2024.

Based on AE Wealth Management's 13F filing for Q2 2024, filed 12 Aug 2024.